Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1002388/000119312509118381/d10k.htm
Exhibit 99.1
ACCELRYS ANNOUNCES FOURTH QUARTER AND FULL YEAR FISCAL 2009
FINANCIAL RESULTS
San Diego, May 21, 2009 Accelrys, Inc. (NASDAQ: ACCL) today reported financial results for the fiscal quarter and full year ended March 31, 2009.
We are pleased with our year end results from both a financial and operational standpoint particularly in light of the worldwide recession said Todd Johnson, Interim President and CEO of Accelrys. We achieved profitability on both a GAAP and non-GAAP basis for the year and increased our cash balance by $5.4 million. We enhanced our life sciences and materials sciences offerings and released Pipeline Pilot Enterprise Server 7.5, the latest version of our industry-leading scientific operating platform. The new release includes enhanced enterprise-level implementation and security capabilities, thereby further enabling the broader deployment of Pipeline Pilot to our customer base. These enhanced enterprise-wide capabilities are enabling our platform to continue to gain momentum, as we have seen substantial increases in the use of our platform within our largest customers, including most of the worlds largest pharmaceutical companies. This success combined with the increased competitiveness of our modeling and simulation products has us entering the new fiscal year stronger, more competitively positioned, and excited about the momentum in our business. This fiscal year we will continue to focus on our broader value proposition by offering integrated solutions that include our modeling and simulation products, our cheminformatics capabilities, and the power and reach of Pipeline Pilot, both to current customers and to new customers in new markets, thereby positioning us for continued growth.
Fourth Quarter 2009 Financial Results:
| Revenue for the quarter ended March 31, 2009 decreased 2% to $20.0 million from $20.4 million for the same quarter of the previous year. |
| Non-GAAP net loss was $1.5 million, or $(0.05) per diluted share, for the current quarter compared to non-GAAP net income of $1.0 million, or $0.04 per diluted share, for the same quarter of the previous year. The non-GAAP net loss in the current quarter included $2.4 million of additional severance expense, as compared to the same quarter of the previous year. |
| GAAP net loss was $2.2 million, or $(0.08) per diluted share, for the current quarter compared to GAAP net loss of $0.5 million, or $(0.02) per diluted share, for the same quarter of the previous year. The GAAP net loss in the current quarter included $2.4 million of additional severance expense, as compared to the same quarter of the previous year. |
Fiscal 2009 Financial Results:
| Revenue for the full year ended March 31, 2009, was $81.0 million, an increase of 2% from $79.7 million for the prior year. |
| Non-GAAP net income was $6.0 million, or $0.22 per diluted share compared to non-GAAP net income of $7.0 million, or $0.26 per diluted share, for the prior year. The non-GAAP net income in the current year included $2.7 million of additional severance expense, as compared to the prior year. |
| GAAP net income was $0.1 million, or $0.00 per diluted share, compared to GAAP net income of $1.3 million, or $0.05 per share, for the prior year. The GAAP net income in the current year included $2.7 million of additional severance expense, as compared to the prior year. |
| At March 31, 2009, the Company had total cash, cash equivalents, restricted cash and marketable securities of $81.8 million, an increase of $5.4 million from March 31, 2008. |
Recent Business and Financial Highlights:
| Released Pipeline Pilot Enterprise Server 7.5, the latest version of the Companys scientific operating platform, with improved enterprise deployment and security capabilities. Pipeline Pilot Enterprise Server 7.5 integrates with Microsoft Office SharePoint Server 2007, enabling users to execute and display applications from the familiar, widely supported SharePoint Server environment. |
| Received the 2009 Frost & Sullivan Growth Strategy Leadership Award for the North American Scientific Business Intelligence Pharmaceutical and Biotechnology Market. The award is given to the company that has bolstered its position in the market during the base year and whose strategy and technological innovation will have a lasting impact on the market. |
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Accelrys, Inc..
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1002388/000119312509118381/d10k.htm
Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.
ContinueRead positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.
ContinueRemove data columns and navigations in order to see much more filing content and tables in one view
ContinueRead both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
ContinueExport Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis
ContinueGet one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREEOur Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
ContinueOur Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
ContinueSee how over 70
Growth, Profitability and Financial Ratios perform over 10 Years